Comerica Securities,Inc. Moderna, Inc. Transaction History

Comerica Securities,Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$118.38 - $210.04 $129,507 - $229,783	1,094 New	1,094 $196,000
Q1 2022 Apr 28, 2022	SELL	$126.46 - $235.05 $112,043 - $208,254	-886 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$225.82 - $368.51 $42,228 - $68,911	187 Added 26.75%	886 $225,000
Q3 2021 Nov 10, 2021	BUY	$221.9 - $484.47 $155,108 - $338,644	699 New	699 $269,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Comerica Securities,Inc., based on Form 13F filings with the SEC.

Stay updated on Comerica Securities,Inc. with notifications on news.